Literature DB >> 6218743

Cardiac performance in thyrotoxicosis: analysis of 10 untreated patients.

A S Iskandrian, L Rose, A H Hakki, B L Segal, S A Kane.   

Abstract

This study attempts to define cardiac performance at rest and during exercise in patients with untreated thyrotoxicosis. We studied 7 women and 3 men, aged 23 to 59 years (40 +/- 10, mean +/- standard deviation [SD]) and compared the results with those obtained in 12 normal subjects. In patients with thyrotoxicosis, the rhythm was sinus and the only untoward symptom was palpitations; the resting electrocardiographic results were normal in 8 patients and showed left ventricular hypertrophy in 2 patients; the left ventricular ejection fraction and volumes (measured by radionuclide ventriculography) were normal at rest. During exercise, 1 patient had dyspnea and 7 had leg fatigue; 2 were asymptomatic. Also, 7 patients had greater than or equal to 5% increase in left ventricular ejection fraction, 2 had no change, and 1 had a decrease. In all 10 patients, the exercise ejection fraction was greater than or equal to 60%. All normal subjects had a greater than or equal to 5% increase in ejection fraction during exercise. There were no significant differences at rest between patients with thyrotoxicosis and normal subjects in blood pressure, ejection fraction, end-diastolic volume, stroke volume, end-systolic volume, or cardiac output, but the heart rate was significantly higher in patients with thyrotoxicosis (91 +/- 10 versus 80 +/- 12 beats/min, p less than 0.05). During exercise, there were no significant differences between patients with thyrotoxicosis and normal subjects in blood pressure, end-diastolic volume, stroke volume, end-systolic volume, or cardiac output. The exercise ejection fraction was significantly lower in patients with thyrotoxicosis than in normal subjects (68 +/- 10% versus 75 +/- 4%, p less than 0.05). Cardiac performance is normal at rest in patients with thyrotoxicosis, but during exercise abnormal left ventricular reserve occurs in some patients.

Entities:  

Mesh:

Year:  1983        PMID: 6218743     DOI: 10.1016/s0002-9149(83)80064-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Heart medications: indications and interactions in stress testing.

Authors:  B H Duncan; L E Sillaman
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

Review 2.  Current concepts in the treatment of congestive heart failure.

Authors:  T B Levine
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

3.  Mechanisms of impaired exercise capacity in short duration experimental hyperthyroidism.

Authors:  W H Martin; R J Spina; E Korte; K E Yarasheski; T J Angelopoulos; P M Nemeth; J E Saffitz
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.